$CHWY

Hu Da-Wai sold $82K of CHWY

Hu Da-Wai (General Counsel & Secretary) sold 4,203 shares of Chewy, Inc. (CHWY) at an average of $19.49 ($19.48–$19.49) across 2 trades on 2026-06-29.

Original reporting
SEC EDGAR · Hu Da-Wai
Published Jun 30, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 30, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHWY
Neutral
medium confidence
Mentioned
$CHWY
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHWYNeutralLow
01

Why it matters

This adds a fresh datapoint to insider activity tracking but does not include any new guidance, legal/regulatory development, or operational change for Chewy.

02

Market read

Traders may monitor whether this is part of a broader insider-selling pattern; otherwise, it is unlikely to materially move the stock on its own.

03

What to watch

No 10b5-1 plan is cited; traders may over-interpret timing. Also, the filing shows the officer ended with 0 shares, which can reflect diversification rather than conviction.

Relevance 3/10Novelty 5/10Timing: Filed June 30 after the June 29 sale; relevant for monitoring insider-flow sentiment into the next sessions.

Background

SEC Form 4 reports an insider transaction by Chewy’s General Counsel & Secretary, Hu Da-Wai, executed June 29 and filed June 30.

Company-level read

Ticker impact

$CHWYNeutralMedium confidence
Context

Chewy general counsel Hu Da-Wai filed an open-market sale of 4,203 shares at ~$19.49, leaving 0 shares after the trade.

Expected impact

Likely limited near-term impact; any effect should fade unless accompanied by broader insider selling or new company fundamentals.

Evidence & confidence

The filing is a single officer sale with no 10b5-1 plan stated and no accompanying operational/regulatory news; insider sales often have mixed interpretation and typically don’t drive price absent additional signals.

Market effects

Minimal—this is company-specific insider activity with no sector-wide read-across provided.

None indicated; US-listed issuer filing only.

None indicated.

Counterpoint

The sale could be purely liquidity-driven (tax/portfolio rebalancing) and not a bearish signal, especially given the small dollar value relative to the company.

Key entities

  • Chewy, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Hu Da-Wai

    General Counsel & Secretary who sold 4,203 shares in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHWYHighAI 8/10

Cat People vs. Dog People: Chewy’s CEO Reveals Who’s Spending More on Their Pets Right Now, and Who’s Cutting Back

Chewy (CHWY) and Petco (WOOF) reported stronger sales in cat products and weaker dog-related sales. General Mills (GIS) saw similar trends, with cat food sales up and dog food down. Cat ownership grew faster than dog ownership, with cats costing less overall. Chewy's Q2 sales rose 7.3% YoY, and it raised full-year guidance, but its stock is down 43.72% YTD.

$CHWYMed

Chewy Puts a $50 Million Price Tag on AI Productivity

Chewy expects AI to reduce costs by $50M in fiscal 2027, up from low tens of millions this year. CEO Sumit Singh attributes savings to AI tools in customer service, pharmacy, and veterinary care. The company's AI assistant, Cai, handles 30% of chats without human agents. AI tools also improve internal operations and pharmacy processes. Chewy built the AI infrastructure in-house, giving it a competitive advantage. The savings will offset wage inflation and fund growth initiatives.

$CHWYMed

Chewy rises as Goldman Sachs maintains Buy rating on stock

Chewy Inc. shares rose 6.78% to $19.06 after Goldman Sachs maintained a Buy rating but lowered its price target to $34 from $46. The company reported Q1 earnings beat but reduced its fiscal 2026 sales outlook, prompting multiple analysts to cut price targets. Chewy's stock is down 56.34% over the past year and trades near its 52-week low.

$CHWYMedAI 8/10

CHWY Is Still Down 34% This Year: Did CHWY Stock Just Find a Bottom?

Chewy (CHWY) shares rose 6% to $21.75, despite a 34% YTD decline. The company reported 7.3% sales growth, raised full-year revenue guidance, and maintained gross margin at 30.4%. Cash decreased to $611M due to acquisitions and share buybacks. The broader pet-care sector has underperformed, with the PAWZ ETF down 10% YTD. Investors await Q3 2026 results to assess margin expansion and potential bottom.

$CHWYMedAI 8/10

Is Chewy’s (CHWY) Margin Story Losing Steam, or Is a 48% Drop the Opportunity?

Chewy (CHWY) reported Q2 2026 net sales of $3.33B, up 7.3%, and adjusted EPS of $0.36. The company raised its full-year outlook, but analysts downgraded the stock and cut price targets. CHWY stock fell 10% intraday after the results. Active customers rose 3.8% to 21.7M. Organic revenue growth slowed to 5.7%, and adjusted EBITDA margin benefited from non-recurring items. Analysts debate whether the slowdown is cyclical or structural.

$CHWYMedAI 8/10

CHWY Stock Hits Over 1-Month Low After Flat Q2 Gross Margin Overshadows Raised Outlook

Chewy Inc. (CHWY) reported Q2 net sales of $3.33B, up 7.3% YoY, meeting estimates. Adjusted EPS rose to $0.36, missing estimates by 1%. Gross margin remained unchanged at 30.4%, while adjusted EBITDA increased 23.7% to $226.7M. Chewy raised its FY26 revenue outlook but narrowed EBITDA margin guidance. CHWY stock fell 7% in morning trade, hitting a one-month low.